This Presolicitation opportunity from Department Of Health And Human Services was posted on October 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
RNA sequencing and whole genome sequencing services
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health, specifically the National Cancer Institute, intends to award a firm-fixed-price purchase order to Plasmidsaurus Inc. for RNA and whole genome sequencing services. This acquisition supports CRISPR research focused on B-cell lymphoma, specifically investigating translocations involving MYC, BCL6, and BCL2, as well as copy number alterations. The services will be used to characterize genome edits, conduct transcriptomic analysis, and observe the effects of various drugs on gene expression to identify novel biological pathways. The government is pursuing a sole-source acquisition based on the specialized capabilities of the Oxford Nanopore Technologies platform used by Plasmidsaurus, which is cited as a faster and more scalable alternative to traditional sequencing methods. While the intent is to award to a single source, interested parties may submit capability statements to the primary point of contact by November 6, 2026, to demonstrate their ability to meet the technical requirements. An award is anticipated approximately five calendar days after the closing date.
General Info
Contract Value
$24,800NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Awardee
PLASMIDSAURUS INC.Award Issued Date
Potential End Date
November 8, 2027Documents
0No documents available
This contract was awarded without public documents.
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
This one is closed. Find the next one like it.
Open contracts like this one, right now:
- SLAC_NOV2026_CHEMICAL_INVENTORY_SYSTEM (CIS)Open now, due in 52 days
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Presolicitation
Contract was awarded
Submission Closed
Organization & Contact Information
Full Description
NOTICE OF INTENT – SOLE-SOURCE ACQUISITION
Notice No.: 75N98027Q00020
The National Institutes of Health (NIH), National Cancer Ibstitute (NCI), intends to award a Firm-Fixed-Price Purchase Order to Plasmidsaurus Inc. for RNA sequencing and whole genome sequencing services for various wild-type, drug-treated cell lines
and samples related to CRISPR research.
Description of the Requirement
The primary objective of this study is to investigate common lymphoma-related translocations involving MYC, BCL6, or BCL2, while also examining copy number alterations and making CNV calls for genes of interest. To achieve this, RNA sequencing will be provided for samples generated in the Staudt laboratory. RNA sequencing is essential for characterizing genome edits and conducting transcriptomic analysis. By utilizing Plasmidsaurus, a faster and more scalable alternative to traditional sequencing methods based on the latest Oxford Nanopore Technologies platform, we aim to generate results that will deepen our understanding of cellular mechanisms involved in B-cell lymphoma and guide future downstream experiments. RNA sequencing and Whole-genome sequencing are required to observe the effects of various drugs on gene expression, identify pathways, and discover novel pathways.
Justification for the Proposed Sole-Source Acquisition
The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
Plasmidsaurus uses the latest Oxford Nanopore Technologies platform, a faster, more scalable alternative to traditional sequencing. Using the latest Oxford Nanopore Technologies platform ensures accurate sequencing, which is crucial for reproducible experiments which will significantly advance our understanding of, and treatment for, B-cell lymphoma, which is vital to cancer research at the National Cancer Institute.
Response Information
This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required preventive maintenance and remedial repair services for the specified instrument and meet all applicable technical and operational requirements.
The Government will review timely submissions to determine whether another responsible source is capable of satisfying the requirement and whether a competitive acquisition is appropriate.
The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement.
Capability statements must be submitted electronically to •••••@•••••.•••Sign up to see this detail no later than 9:00 a.m. EDT on November 6, 2026.
Please reference Notice No. 75N98027Q00043 in the subject line of the submission.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Get AI-powered intelligence on the opportunities still open
Every solicitation package arrives shredded into a compliance breakdown and matched to your past performance, with incumbent history and alerts on amendments and award.
Join 750+ contractors already using CLEATUS
